VANDELLI, Maria Angela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 39.400
EU - Europa 22.778
AS - Asia 18.437
SA - Sud America 2.440
AF - Africa 445
OC - Oceania 70
Continente sconosciuto - Info sul continente non disponibili 30
Totale 83.600
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 38.788
GB - Regno Unito 6.108
SE - Svezia 5.394
IT - Italia 5.272
CN - Cina 5.144
SG - Singapore 5.139
HK - Hong Kong 2.282
VN - Vietnam 1.843
BR - Brasile 1.805
DE - Germania 1.210
FI - Finlandia 829
TR - Turchia 811
UA - Ucraina 784
RU - Federazione Russa 774
BD - Bangladesh 737
FR - Francia 709
KR - Corea 621
IN - India 469
BG - Bulgaria 306
CA - Canada 298
NL - Olanda 256
AR - Argentina 207
ID - Indonesia 187
JP - Giappone 185
IQ - Iraq 168
MX - Messico 164
ZA - Sudafrica 148
IE - Irlanda 147
ES - Italia 132
PK - Pakistan 124
RO - Romania 124
PL - Polonia 120
EC - Ecuador 112
BE - Belgio 107
AE - Emirati Arabi Uniti 104
CO - Colombia 96
CH - Svizzera 76
LT - Lituania 66
MY - Malesia 66
AU - Australia 61
VE - Venezuela 61
IR - Iran 58
CL - Cile 56
PH - Filippine 56
AT - Austria 55
MA - Marocco 55
CZ - Repubblica Ceca 53
EG - Egitto 51
UZ - Uzbekistan 51
SA - Arabia Saudita 46
IL - Israele 43
TN - Tunisia 43
DZ - Algeria 37
LU - Lussemburgo 37
PY - Paraguay 36
PE - Perù 35
PT - Portogallo 35
NP - Nepal 33
TW - Taiwan 33
JO - Giordania 32
TH - Thailandia 31
JM - Giamaica 29
KE - Kenya 29
GR - Grecia 27
EU - Europa 23
AZ - Azerbaigian 21
KZ - Kazakistan 20
CR - Costa Rica 18
DK - Danimarca 18
ET - Etiopia 18
DO - Repubblica Dominicana 17
MD - Moldavia 17
UY - Uruguay 17
AL - Albania 16
HU - Ungheria 16
TT - Trinidad e Tobago 15
BO - Bolivia 14
LB - Libano 14
OM - Oman 14
RS - Serbia 14
SN - Senegal 14
KG - Kirghizistan 12
BY - Bielorussia 11
NI - Nicaragua 11
NO - Norvegia 11
PA - Panama 10
PR - Porto Rico 10
SI - Slovenia 10
CY - Cipro 9
EE - Estonia 9
GT - Guatemala 9
NZ - Nuova Zelanda 9
BH - Bahrain 8
HR - Croazia 8
AM - Armenia 7
KH - Cambogia 7
LA - Repubblica Popolare Democratica del Laos 7
LV - Lettonia 7
LY - Libia 7
PS - Palestinian Territory 7
Totale 83.450
Salva come PNG Salva come JPEG
Città #
Southend 4.606
Ashburn 3.687
Stockholm 3.593
Santa Clara 3.519
Singapore 3.203
Fairfield 2.822
Hong Kong 2.238
Chandler 2.167
Woodbridge 2.027
Hefei 1.714
Chicago 1.559
Jacksonville 1.534
Houston 1.425
San Jose 1.376
Seattle 1.201
Wilmington 1.172
Dearborn 1.131
Ann Arbor 1.073
Nyköping 1.028
Beijing 965
Cambridge 955
Los Angeles 943
London 783
Modena 650
Council Bluffs 644
Ho Chi Minh City 607
Seoul 529
Helsinki 521
The Dalles 462
Izmir 461
New York 443
Hanoi 428
Salt Lake City 395
Milan 382
Princeton 313
Dallas 293
Sofia 291
San Diego 270
Eugene 265
Rome 256
Buffalo 255
Lauterbourg 254
Bologna 220
Moscow 202
Des Moines 193
Shanghai 186
Redwood City 185
São Paulo 172
Tampa 167
Elk Grove Village 166
Munich 160
Orem 141
Tokyo 133
Frankfurt am Main 127
Bremen 124
Jakarta 117
Dublin 116
Fremont 113
Phoenix 111
Columbus 98
Boardman 97
Reggio Emilia 95
Brussels 92
Chennai 91
Lancaster 91
Guangzhou 87
Naples 85
Miami 82
Falls Church 81
Sterling 75
Johannesburg 73
Da Nang 71
Warsaw 71
Atlanta 70
Haiphong 69
Parma 68
Toronto 62
Montreal 60
Washington 60
Turin 59
Amsterdam 58
Baghdad 58
Denver 57
Brooklyn 55
Como 53
Dulles 53
Nanjing 53
Florence 52
Bari 50
Catania 49
Mumbai 49
Norwalk 49
Turku 49
Detroit 48
Mexico City 47
Kent 46
Miano 45
Tashkent 44
Kunming 42
Rio de Janeiro 42
Totale 57.709
Salva come PNG Salva come JPEG
Nome #
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol 2.311
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 2.032
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 593
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 506
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 493
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA) 492
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 476
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 466
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 460
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 456
The novel heptyl phorolic acid cannabinoids content in different Cannabis sativa L. accessions 454
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 444
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 436
PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid 436
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 431
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 427
Cationic liposomes for gene transfection 421
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 421
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 420
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 420
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 418
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution 415
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 414
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 408
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 406
Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method 400
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 399
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 399
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 398
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 395
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 392
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 387
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 382
A Metabolomic Approach Applied to a LiquidChromatography Coupled to High-ResolutionTandem Mass Spectrometry Method (HPLC-ESI-HRMS/MS): Towards the ComprehensiveEvaluation of the Chemical Composition ofCannabis Medicinal Extracts 379
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 376
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 373
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog 372
Nanoparticle transport across the blood brain barrier 369
Polymeric nanoparticles for the drug delivery to the central nervous system 369
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 368
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 367
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 365
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 362
Distribution of drugs in polymers loaded by swelling 361
Brain targeting with polymeric nanoparticles: which administration route should we take? 361
Bead coating process via an excess of crosslinking agent 360
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 360
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 359
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 358
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 355
Protein corona and nanoparticles: How can we investigate on? 352
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 348
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 348
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 346
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 345
Microwave-treated gelatin microspheres as drug delivery system 343
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 341
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 340
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol 337
The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica 334
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 334
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 334
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 331
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 331
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 331
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 330
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 329
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 329
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 329
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 327
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 326
A theoretical model for the calculation of the drug distribution profile in matrices of different shape to achieve the desired drug release kinetics 326
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 326
Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry 326
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study 325
Pharmaceutical and biomedical analysis of cannabinoids: A critical review 324
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 324
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 323
Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog 323
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol 323
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 322
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 320
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives 318
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 318
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 318
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 315
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 314
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 314
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 313
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 313
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 311
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 309
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 308
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 307
Functionalization of liposomes: microscopical methods for preformulative screening 306
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 306
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 305
Colloidal systems for CNS drug delivery 302
Pitfalls in the analysis of phytocannabinoids in cannabis inflorescence 299
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 298
Totale 40.223
Salva come PNG Salva come JPEG
Categoria #
all - tutte 303.181
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 303.181
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021370 0 0 0 0 0 0 0 0 0 0 0 370
2021/20225.454 242 633 533 395 201 251 288 344 626 403 891 647
2022/20236.359 751 688 500 621 732 933 171 561 734 117 244 307
2023/20244.469 224 264 273 353 912 463 524 576 161 139 209 371
2024/202513.981 758 200 301 1.052 2.683 1.898 1.053 923 1.353 529 1.477 1.754
2025/202629.992 1.679 978 2.015 3.195 4.773 1.796 2.808 1.298 6.270 2.407 1.440 1.333
Totale 84.093